SURMODICS INC
SURMODICS INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 26 | 29 | 30 | 36 | 24 | 33 | 23 | 41 | 45 | 19 | 26 | 19 | |||||
Available For Sale Securities Debt Securities Curr… | 6 | 2 | - | 4 | 14 | 8 | 12 | 4 | - | - | - | - | |||||
Accounts Receivable Net Current | 13 | 12 | 13 | 13 | 13 | 12 | 13 | 11 | 12 | 12 | 10 | 10 | |||||
Contract With Customer Asset Net | - | - | - | - | - | 11 | 9 | 8 | 8 | 8 | 7 | 7 | |||||
Contract With Customer Asset Net Current | 9 | 10 | 10 | 10 | 10 | - | - | 8 | - | - | - | - | |||||
Inventory Net | 16 | 16 | 15 | 15 | 15 | 15 | 14 | 15 | 15 | 14 | 13 | 12 | |||||
Income Taxes Receivable | 1 | - | - | - | - | 1 | 0 | 0 | - | - | 0 | 2 | |||||
Prepaid Expense And Other Assets Current | 4 | 3 | 4 | 3 | 3 | 4 | 8 | 7 | 7 | 8 | 8 | 7 | |||||
Assets Current | 76 | 72 | 72 | 81 | 80 | 84 | 80 | 87 | 86 | 61 | 64 | 58 | |||||
Property Plant And Equipment Net | 23 | 23 | 24 | 25 | 25 | 26 | 26 | 26 | 27 | 28 | 28 | 27 | |||||
Intangible Assets Net Excluding Goodwill | 22 | 21 | 21 | 24 | 24 | 25 | 26 | 26 | 28 | 29 | 29 | 28 | |||||
Goodwill | 46 | 44 | 42 | 45 | 43 | 44 | 44 | 43 | 44 | 44 | 43 | 41 | |||||
Other Assets Noncurrent | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | |||||
Assets | 170 | 163 | 164 | 179 | 177 | 183 | 180 | 186 | 189 | 166 | 170 | 158 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 4 | 2 | 3 | |||||
Accrued Liabilities Curre… | |||||||||||||||||
Employee Related Liabilities Current | 7 | 6 | 5 | 11 | 8 | 6 | 4 | 10 | 8 | 6 | 4 | 9 | |||||
Accrued Liabilities Current | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 5 | 6 | 7 | 6 | |||||
Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | - | 10 | |||||
Deferred Revenue Current | 1 | 0 | 0 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 4 | 4 | |||||
Accrued Income Taxes Current | 0 | 0 | 2 | 1 | 0 | - | - | - | 12 | - | - | - | |||||
Liabilities Current | 19 | 14 | 13 | 21 | 20 | 19 | 16 | 24 | 32 | 19 | 17 | 32 | |||||
Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | 29 | - | |||||
Long Term Debt | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 | 29 | 29 | - | - | |||||
Deferred Revenue Noncurrent | - | - | - | - | - | - | 2 | 2 | 3 | 3 | 4 | 5 | |||||
Deferred Income Tax Liabilities Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Other Liabilities Noncurrent | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 10 | 10 | 10 | 11 | |||||
Liabilities | 59 | 53 | 52 | 60 | 59 | 59 | 58 | 66 | 76 | 64 | 62 | 50 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Additional Paid In Capital Common Stock | 48 | 47 | 45 | 45 | 42 | 40 | 38 | 37 | 34 | 32 | 30 | 29 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 1 | -4 | -6 | -2 | -4 | -4 | -3 | -5 | -3 | -4 | -5 | -10 | |||||
Retained Earnings Accumulated Deficit | 62 | 67 | 72 | 76 | 79 | 87 | 86 | 87 | 81 | 73 | 81 | 89 | |||||
Stockholders Equity | 111 | 110 | 112 | 119 | 118 | 124 | 122 | 120 | 112 | 103 | 107 | 108 | |||||
Liabilities And Stockholders Equity | 170 | 163 | 164 | 179 | 177 | 183 | 180 | 186 | 189 | 166 | 170 | 158 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Common Stock Shares Authorized | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | |||||
Common Stock Shares Issued | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |||||
Shares Outstanding | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.78% | -14.37% | -22.29% | 2.46% | 3.53% | 7.85% | -3.87% | -15.45% | -23.02% | - | - | - |
| 2024 | 1.11% | -14.71% | -18.32% | 3.15% | 25.86% | 24.99% | -4.08% | -5.17% | -7.58% | 2.20% | -1.86% | -13.07% |
| 2023 | -23.29% | -24.54% | -23.68% | -23.44% | 3.51% | 24.06% | 14.91% | -0.49% | -9.39% | 10.51% | -1.26% | -4.22% |
| 2022 | - | - | - | - | - | - | - | - | - | -4.65% | -0.28% | -20.29% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.91 | 5.14 | 5.45 | 3.96 | 3.98 | 4.39 | 4.84 | 3.62 | 2.68 | 3.20 | 3.73 | 1.80 | |||||
| Quick Ratio | 2.88 | 3.76 | 3.99 | 3.08 | 3.05 | 3.37 | 3.50 | 2.69 | 2.00 | 2.05 | 2.53 | 1.22 | |||||
| Working Capital | 56.55M | 57.80M | 58.66M | 60.76M | 60.16M | 65.07M | 63.33M | 62.74M | 53.80M | 42.11M | 47.20M | 25.51M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.53 | 0.48 | 0.46 | 0.50 | 0.50 | 0.47 | 0.48 | 0.55 | 0.68 | 0.62 | 0.58 | 0.46 | |||||
| Interest Coverage TTM | -3.54 | -3.56 | -2.21 | -1.59 | -2.11 | 5.43 | 3.39 | 1.48 | 0.35 | -13.49 | -20.10 | -36.95 | |||||
| Debt Ratio | 0.34 | 0.32 | 0.32 | 0.33 | 0.33 | 0.32 | 0.32 | 0.35 | 0.40 | 0.38 | 0.37 | 0.32 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.70 | 0.70 | 0.73 | 0.69 | 0.66 | 0.82 | 0.79 | 0.77 | 0.72 | 0.59 | 0.57 | 0.57 | |||||
| Days Sales Outstanding TTM | 40.12 | 35.89 | 37.07 | 34.95 | 37.98 | 31.20 | 30.35 | 29.32 | 29.53 | 41.04 | 32.38 | 35.83 | |||||
| Receivables Turnover TTM | 9.10 | 10.17 | 9.85 | 10.44 | 9.61 | 11.70 | 12.02 | 12.45 | 12.36 | 8.89 | 11.27 | 10.19 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.23 | -1.39 | -1.01 | -0.82 | -0.10 | 0.95 | 0.39 | -0.11 | -1.63 | -2.56 | -2.31 | -1.96 | |||||
| Free Cash Flow Per Share TTM | -0.25 | -0.52 | -0.14 | -0.23 | -0.41 | 1.59 | 0.70 | 0.54 | 0.29 | -1.84 | -1.76 | -1.48 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 73.09% | 73.37% | 74.77% | 73.81% | 74.02% | 79.11% | 79.38% | 81.17% | 81.99% | 78.88% | 79.28% | 79.65% | |||||
| Operating Profit Margin TTM | -10.22% | -10.26% | -6.22% | -4.48% | -6.19% | 13.50% | 8.72% | 3.88% | 0.76% | -26.77% | -25.41% | -22.11% | |||||
| Net Profit Margin TTM | -14.59% | -16.34% | -11.48% | -9.15% | -1.16% | 9.44% | 3.99% | -1.16% | -17.58% | -34.92% | -31.71% | -27.29% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -0.02% | -14.96% | -9.23% | -4.91% | -7.49% | 38.84% | 35.65% | 32.65% | 33.36% | 6.21% | -3.74% | -4.93% | |||||
| Net Income Growth (1Y) | 1,159.97% | -247.12% | -360.95% | 651.43% | -93.91% | -137.55% | -117.09% | -94.37% | 78.87% | 243.38% | -2,001.41% | -743.71% | |||||
| EPS Growth (1Y) | 1,150.18% | -245.82% | -358.58% | 644.95% | -93.96% | -137.23% | -116.95% | -94.41% | 77.33% | 240.61% | -1,987.13% | -736.73% | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -3.55M | -7.44M | -1.93M | -3.24M | -5.86M | 22.56M | 9.86M | 7.60M | 4.02M | -25.76M | -24.56M | -20.59M | |||||
| Net Debt | 3.39M | 445.00K | -554.00K | -6.56M | 5.22M | -3.55M | 6.09M | -12.01M | -15.23M | 10.12M | 3.07M | -9.00M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
SURMODICS INC (SRDX) — SEC Financial Statements & Analysis
SURMODICS INC (SRDX) is a surgical & medical instruments & apparatus company, incorporated in MN. SURMODICS INC trades on Nasdaq as: SRDX. Based on its latest SEC filing (Form 10-Q, period ending 2025-06-30), SURMODICS INC reported a -0.02% year-over-year revenue growth, a Gross Profit Margin of 73.09% (TTM), a Debt-to-Equity ratio of 0.53x. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -0.02%
- Gross Profit Margin TTM
- 73.09%
- Debt To Equity
- 0.53x
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SURMODICS INC in?
SURMODICS INC (SRDX) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does SRDX trade on?
SURMODICS INC (SRDX) trades on the Nasdaq.
Where is SURMODICS INC incorporated?
SURMODICS INC is incorporated in MN.